Latest Olfactory Bioscience (OLFC) Headlines NOXO

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Olfactory Bioscience (OLFC) Headlines

NOXO Autism Balmâ?¢ and NOXO Anxiety Relief Proâ?¢ were OLFC's Best Selling and Most Effective Topical Alternative Medicines in 2013
ACCESSWIRE - Thu Jan 23, 6:11AM CST
Special Offer: Purchase TWO and get ONE free.**

2013 Had Significant Advances in Autism, But Only OLFC's NOXO Autism Balm(tm) is Now Helping Individuals, Families, Doctors, Therapists and Caregivers Involved with Hypersensitivities
ACCESSWIRE - Tue Jan 07, 6:19AM CST
PHILADELPHIA, PA / ACCESSWIRE / Olfactory Biosciences Corp (OLFC) the maker of NOXO Autism Balm(TM), is pleased to announce today that they are receiving positive proof of product claims / testimonials from families, doctors, therapists and caregivers involved with Autism Spectrum Disorders. And in addition, one of the top advances in Autism Spectrum Diseases.

OLFC Introduces a Scientific Breakthrough Balm that Prevents Overeating
ACCESSWIRE - Wed Dec 11, 4:30AM CST
NOXO Appetite Control Balm™ is to be used in conjunction with any and all diets plans. It strengthens willpower and minimizes cravings assuring successful dieting. Developed by Dr. V. Ruth Pinney, Director of Research and a corporate director at Olfactory Biosciences Corp.

OLFC Launches Improved High-level Wellness Products for 2014
ACCESSWIRE - Mon Dec 02, 4:11AM CST
NOXO Autism Aid Balm(tm): NOXO Anxiety Relief Pro(tm): NOXO Appetite Control Pro(tm): NOXO Sleep Easy Pro(tm): NOXO Odor Defense Pro(tm)

NOXO Autism Balmâ?¢, From OLFC, Gets Rave Review From Mom Of 11-Year-Old with ASD
ACCESSWIRE - Tue Nov 26, 6:01AM CST
PHILADELPHIA, PA / ACCESSWIRE / Olfactory Biosciences Corp (OTC: OLFC) is pleased to announce today that they are receiving proof of product claims / real-time assessments from families, doctors, therapists and caregivers involved with Autism Spectrum Disorders.

OLFC's NOXO Autism Balm(TM) is Helping Individuals Struggling with Autism and Families, Doctors, Therapists and Caregivers Involved with Them
ACCESSWIRE - Fri Nov 22, 6:13AM CST
PHILADELPHIA, PA / ACCESSWIRE / Olfactory Biosciences Corp (OTC: OLFC) the maker of NOXO Autism Balm™, is pleased to announce today that they are receiving proof of product claims / testimonials from families, doctors, therapists and caregivers involved with Autism Spectrum Disorders.

Autism Calming and Soothing Balm by OLFC's Dr. V. Ruth Pinney Is Realizing Its Vision of Helping Those With Autism
Marketwire - Thu Nov 21, 6:07AM CST
Olfactory Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Balm(TM), is pleased to announce today that they are receiving endorsements from a wide variety of individuals involved with Autism Spectrum Disorders. NOXO Autism Balm(TM) was created with one goal in mind and that was to provide relief to as many people affected by Autism as possible. OLFC is aware that NOXO Autism Balm(TM) will help select individuals affected by odor sensitivities. OLFC has been able to identify that individuals with odor sensitivities can be helped by blocking the odor from being smelled, as well as, providing other proprietary ingredients that have a calming and soothing affect. It is non-invasive and applied to the upper lip just below the nostrils for maximum effect.

OLFC's Dr Ruth Pinney Invents New Anxiety Relief Proâ?¢ the First Important Natural Alternative to the Dangerous Commonly Prescribed â??Benzo" Drugs
ACCESSWIRE - Tue Nov 19, 5:10AM CST
PHILADELPHIA - Olfactory Biosciences Corp ( OTC: OLFC) today announced that it has released Dr. Pinney's New NOXO Anxiety Relief Pro(TM) the resulting combination of NOBEL Prize Winning science and NOXO's advanced olfactory receptor administration delivery system. Unlike popular and addictive "Benzo" drugs which are commonly prescribed and taken internally, and include Xanax(R), Ativan(R), Klonopin(R) and more, NOXO Anxiety Relief Pro(TM) is a topical gel and is applied under the nose where the olfactory receptors of the brain pick up the scents and stimulate the release of powerful neurotransmitters and directly block the startle reflex. The anxiety is blocked in a natural and drug free manner.

OLFC Announces NOXO Autism Balm(TM) as Number One of the Company's Top Three Wellness Products for 2013
ACCESSWIRE - Tue Nov 05, 6:13AM CST
Philadelphia, PA / ACCESSWIRE / Olfactory Biosciences Corp.'s (OLFC) Chief Scientist Dr. V. Ruth Pinney and developer of NOXO natural Wellness products, announced the three top balms based on sales and effectiveness for 2013.

Halloween Autism Charity Blitz, OLFC to Donate 20% of All Autism Balm Sales to Autism Charity of Buyer's Choice
Marketwire - Thu Oct 31, 6:01AM CDT
Olfactory Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Balm(TM), is pleased to announce today that they are donating 20% of all NOXO Autism Balm(TM) sales to the charity of the buyers choice over the next 24 hours. All a buyer needs to do is enter the name of their preferred Autism Charity in the notes field on their Amazon.com order and the charity indicated will receive a donation of 20% of that sale.

Four Stocks That Deserve Your Attention and Feature Alert
Marketwire - Fri Oct 25, 6:30AM CDT
Gold Coast Mining Corp (PINKSHEETS: GDSM) engages in the extraction of mineral properties in Prescott, Arizona. It primarily focuses on gold, silver, and other materials extraction. The company, through a joint venture agreement with Western Sierra Mining Corp., holds 50% interest in the Ore Cache mine located to south of Prescott, Arizona; and the Sun Gold Mine project, which consists of 5 unpatented mining claims that is located in the Prescott, Arizona. Find out about GDSM's alliance within the oilfield by following this link: http://bit.ly/ResearchReportsGDSM

NOXO Anxiety Relief Pro Balmâ?¢ by Dr. V. Ruth Pinney Introduced and Added to Line of OLFC Natural Wellness Products
ACCESSWIRE - Thu Oct 24, 5:56AM CDT
Philadelphia, PA - Olfactory Biosciences Corp. (OLFC) and chief scientist Dr. V. Ruth Pinney, the makers of NOXO Autism Aid Balm(TM) announce today the successful introduction of their innovative NOXO Anxiety Relief Pro Balm(TM). NOXO's new solution that provides unprecedented hope for individuals who experience anxiety and know all too well the overwhelming feelings of fear and panic that can make life difficult for them.

Olfactory Biosciences Corp. Offers Reseller/Affiliate Program for Autism Aid Balm
Marketwire - Fri Oct 18, 6:38AM CDT
Olfactory Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Aid Balm(TM), is pleased to announce today that they are accepting requests for reseller opportunities. There are limited opportunities available. This decision has come as a result of increasing sales volumes and the desire OLFC has for people to have a more personalized attention from a local reseller.

New Autism Balm Inventor, Dr. Penney Gives Answers to Common Questions.
ACCESSWIRE - Tue Oct 15, 7:09AM CDT
Philadelphia, PA - Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Balm(TM) announce today that with the success of their innovative Autism

New Autism Balm Inventor, Dr. Ruth V. Penney Wins NOXO Prize Award for Hailed "Anxiety Eraser" that is Non-Invasive, Normalizes Brain Patterns and Provides Tranquility
ACCESSWIRE - Fri Oct 11, 5:16AM CDT
Philadelphia,PA - Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Balm(TM) announced the company's NOXO Prize Award in Science for the success of the innovative Autism balm. OLFC 's Chief Scientist Dr. V. Ruth Pinney and developer of NOXO

New Autism Balm Invented by Dr. Pinney: Non-Invasive, Normalizes Brain Patterns, Provides Tranquility
ACCESSWIRE - Thu Oct 10, 5:01AM CDT
Philadelphia, PA - Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Balm(TM) announce today the success of their innovative Autism balm. OLFC 's Chief Scientist Dr. V. Ruth Pinney and developer of NOXO Autism Balm(TM) offers a life changing solution that provides unprecedented hope for families isolated by behavioral issues related to sensitivities and overstimulation in children with Autism.

Can it really be that simple? Autism Balm by Dr. V. Ruth Pinney
ACCESSWIRE - Wed Oct 09, 5:55AM CDT
Philadelphia, PA - Olfactory Biosciences Corp.'s (OLFC) Chief Scientist Dr. V. Ruth Pinney and developer of NOXO Autism Balm™ has created something that to some would be too simple a solution on the surface to the quite sophisticated and seemingly complex problem of reducing coping behaviors in Autistic children and adults. "Simplicity is the ultimate sophistication." Words by Leonardo da Vinci that explain Dr. Pinney's solution to provide relief from an invisible menace

New Autism Aid, Dr. Ruth. V. Pinney's Incredible Natural Formulation, Enables Brain Waves and Behavioral Patterns to Go Back to Normal. Customer Response Enthusiastic.
ACCESSWIRE - Mon Oct 07, 11:08PM CDT
Philadelphia, PA / ACCESSWIRE / Olfactory Biosciences Corp.'s (OLFC) Chief Scientist Dr. V. Ruth Pinney and developer of NOXO Autism Aid Balm™ said that what makes NOXO's Autism Aid Balm™ unique is that it, "Is a simple, but powerful way to 'tone down' an autistic child's overwhelming senses and sensory perceptions.

â??I Am in Disbelief How this Autism Balm Brought some Tranquility in our Home,â? A. A. Chang, RN, L A Sheriff Depart.
ACCESSWIRE - Thu Sep 19, 6:45AM CDT
Philadelphia, PA - Olfactory Biosciences Corp.'s (OLFC) Chief Scientist Dr. V. Ruth Pinney . invented proprietary NOXO Autism Balm(TM) to reduce coping behaviors. Dr. Pinney noted that what makes NOXO's Autism Balm unique is that it, "Is a simple, but powerful way to 'tone down' their overwhelming perceptions. The Autism Balm works well with most children that have Autism Spectrum Disorders (ASD). It is successful because it targets sensitivities naturally, changing the child's perception to sensory inputs in a direct, safe way!" www.noxoinfo.com/autism

New Proprietary Autism Balmâ?¢ Invention That Reduces Coping Behaviors Now at New Lower Pricing
ACCESSWIRE - Wed Sep 18, 5:30AM CDT
Philadelphia, PA- (Accesswire) - Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Balm(TM) are pleased to announce today that we are listening to customers and that many have mentioned the difficult economy and how it is making it a hardship for them to afford NOXO Autism Balm(TM). In response OLFC we would like to show our dedication to our new friends in the Autism community by lowering the price to $29.95 on a trial basis. If purchase volumes continue to dramatically increase and help us justify this price drop it will remain permanent in order to remain affordable for those who need it.

Olfactory Bioscience (OLFC) Stock Research Links

OLFC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NEXCOM Fortifies Academic Networks with NGFW Platforms

Updated Category News Views 1

Shielding Academic Networks in a Digital Era NEXCOM's stepping up to the plate to tackle the runaway train that is digital education. With classrooms going virtual and everything but the kitchen sink being plugged online, it's no wonder our beloved academic institutions are scrambling to hold the fort against cyber threats. Enter NEXCOM with their Next-Generation Firewall...

Continue Reading
Sunlife Partners With Rippling to Streamline Benefits

Updated Category News Views 3

Sunlife Enters the Tech Game It ain't your granddaddy's insurance world no more. Sunlife U.S. is hopping on the tech bandwagon, joining Rippling's Preferred Carrier Program to make employee benefits slicker and faster. This isn't just about insurance paperwork; it's about reshaping how businesses handle their payroll, IT, and HR under one digital roof. Why it Matters for...

Continue Reading
RavenPack's Data Innovation: Sharpening Financial Analysis

Updated Category News Views 6

Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...

Continue Reading
Fluence Energy Faces Massive Class Action Over Losses

Updated Category News Views 7

Fluence Energy in Hot Water: Class Action Alert What a time to be catching the news on Fluence Energy, Inc. (NASDAQ: FLNC), a company that seemed like it was on the verge of taking the market by storm. But instead of riding high, they’re stuck in the mud, dealing with a securities class action lawsuit. This comes after a relentless punch to their market cap—about $3...

Continue Reading
Hard Rock Casino Tejon Commences $725M Expansion Project

Updated Category News Views 4

Ground Broken for Hard Rock Casino Tejon's Ambitious Expansion Who’s got a shovel ready? Hard Rock Casino Tejon does, kicking off a $725 million expansion that's turning heads all the way from Bakersfield to Los Angeles. Let's get something straight: this ain’t just another face-lift. We’re talking about a full-on transformation of the place into a plush resort...

Continue Reading
ServiceTitan Faces Investigation: Stock Tanks 30%

Updated Category News Views 1

ServiceTitan Lands in Hot Water Here we go again. News rolled in on September 8, 2026, catching investors like a deer in headlights. ServiceTitan, the operating systems provider that’s been riding the waves of the building and trades industries, just got clobbered with an investigation. As if grappling with their Max AI rollout wasn't enough, Robbins Geller Rudman &...

Continue Reading
Compass Hit by Securities Fraud Suit; Investor Action Urged

Updated Category News Views 2

Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...

Continue Reading
CSL Names Deborah Waterhouse as CEO in Strategic Move

Updated Category News Views 9

A Key Transition: Deborah Waterhouse Takes the Helm In a move that's sure to jolt the biopharma sphere, CSL Limited just handed the CEO reins over to Deborah Waterhouse. Set to start officially on February 1, 2027, this strategic appointment seems well plotted after a diligent global hunt by CSL's board for someone who can drive their enterprise into its next surge of...

Continue Reading
deepset Strikes with AI Cost Solutions for Key Sectors

Updated Category News Views 10

The AI Cost Conundrum: deepset's Strategic Leap deepset's latest move unleashes a fresh wind in the AI sector, tackling the financial drag from running high-caliber AI agents. With its Haystack Enterprise Platform, deepset isn't just coddling around the edges—it's going for the heart, where the budget bleeds most, and patching it up with a tech-savvy twist. Surfing the...

Continue Reading
Sony's Game-Changing Sensor Reshapes Medical Endoscopy

Updated Category News Views 0

In a world where medical tech innovation can make the difference between life and death, Sony’s latest feat will turn some heads in the healthcare industry. This ain’t about another PlayStation release; we’re talking the IMX742 CMOS image sensor crafted for single-use endoscopes. As far as breakthroughs go, the microscopic square sensor packs a surprising punch by...

Continue Reading

Top 5 Most Recently Viewed Articles

Inception Growth Extends Special Meeting and Redemption Deadline

Updated Category News Views 165

Inception Growth Acquisition Limited Postpones Special Meeting New York, June 26, 2025 - Inception Growth Acquisition Limited (NASDAQ: IGTA), a company formed for investment purposes, has decided to postpone its special meeting of shareholders originally scheduled for July 1, 2025. The new date for this significant event is now set for July 14, 2025, at 10:00 a.m. Hong...

Continue Reading
Market Trends Amid Inflation Concerns: Insights on Key Stocks

Updated Category News Views 98

Recent Market Performance and Its Implications As U.S. equities reached new record highs this week, a sudden halt in momentum arose as concerns regarding inflation cast shadows over future growth. Investors are now grappling with complex inflation data, which could significantly impact the Federal Reserve's strategy regarding interest rates. Inflation Data and Economic...

Continue Reading
Insight into Man Group PLC's Position Regarding Dalata Hotel Group

Updated Category News Views 96

Understanding Man Group PLC's Role in Recent Disclosures Man Group PLC, a distinguished player in the financial services sector, has provided significant updates regarding its position in Dalata Hotel Group plc. This disclosure is particularly relevant for investors tracking the dynamics within the hospitality and investment landscapes. Key Disclosure Information In...

Continue Reading
NBC Sports Makes History with Primetime Kentucky Oaks 2026

Updated Category News Views 173

NBC Sports Makes History with Primetime Kentucky Oaks 2026 Churchill Downs Incorporated and NBC Sports have announced an exciting new chapter in the legacy of the Kentucky Oaks. For the very first time, the renowned race will be televised in primetime, allowing fans to immerse themselves in the thrilling atmosphere of this esteemed event on the evening of May 1, 2026, at...

Continue Reading
Acadia Healthcare Facing Class Action: Legal Insights for Investors

Updated Category News Views 52

Overview of Acadia Healthcare's Legal Challenges Recent developments have brought Acadia Healthcare Company, Inc. (NASDAQ: ACHC) into the limelight due to allegations surrounding misleading business practices. This situation has led to a closer look at the company's operations and its level of transparency. Investigation into Securities Claims The Rosen Law Firm, a...

Continue Reading